- NCIt
- C9479
Loading cancer entity…
Loading cancer entity…
Clinical trials
78 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (3)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04242667 | Penn Biobank Return of Research Results Program | completed | N/A | 260 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT03749980 | MyVHL: Patient Natural History Study(MyVHL) | recruiting | — | 10,000 | Joshua Mann, MPHOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| Quebec Pancreas Cancer Study(QPCS) |
| unknown |
| — |
| 2,000 |
| George ZogopoulosOTHER |
| 1 |
| Apr 17, 2024 |
| clinicaltrials |
| NCT00390325 | Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer | completed | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Feb 6, 2024 | clinicaltrials |
| NCT06163365 | Inherited Cancer Early Diagnosis (ICED) Study(ICED) | unknown | — | 100 | Royal Marsden NHS Foundation TrustOTHER | 1 | Dec 8, 2023 | clinicaltrials |
| NCT05534854 | Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes | unknown | — | 500 | RenJi HospitalOTHER | 1 | Aug 31, 2023 | clinicaltrials |
| NCT02560896 | Understanding Genetic Incidental Findings in Your Family (UNIFY Study)(UNIFY) | completed | — | 12 | Mayo ClinicOTHER | 1 | Jun 6, 2023 | clinicaltrials |
| NCT04603365 | Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer | withdrawn | Phase 2 | 0 | Jonsson Comprehensive Cancer CenterOTHER | 0 | May 17, 2023 | clinicaltrials |
| NCT05805982 | Educational Video Versus In-person Genetic Counseling for Hereditary Cancer | completed | N/A | 251 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranOTHER | 1 | Apr 10, 2023 | clinicaltrials |
| NCT05763472 | Breast Cancer After Ovarian Cancer During and/or After Therapy: Genomic Evaluation(Gen-eva) | unknown | — | 10 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 10, 2023 | clinicaltrials |
| NCT05740111 | The PREPAIRD Study: Personalized Surveillance for Early Detection of Pancreatic Cancer in High Risk Individuals(PREPAIRD) | enrolling by invitation | N/A | 200 | Oslo University HospitalOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT05717634 | Endometrial Changes in Breast Cancer Women. | unknown | — | 829 | Regina Elena Cancer InstituteOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT01013129 | Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer | completed | — | 748 | Portland VA Medical CenterFED | 1 | Nov 11, 2021 | clinicaltrials |
| NCT03959267 | Testing a Culturally Adapted Telephone Genetic Counseling Intervention | completed | N/A | 37 | Georgetown UniversityOTHER | 1 | Sep 1, 2021 | clinicaltrials |
| NCT03982446 | Germline Mutations in Pancreatic Adenocarcinoma(PaMPA) | completed | — | 549 | Hellenic Cooperative Oncology GroupOTHER | 1 | Feb 12, 2021 | clinicaltrials |
| NCT02381015 | Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a | completed | N/A | 700 | Endeavor HealthOTHER | 0 | Nov 22, 2019 | clinicaltrials |
| NCT03950908 | Biopsy Technique for Endoscopic Surveillance of Hereditary Diffuse Gastric Cancer | completed | N/A | 48 | University of CambridgeOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT00727532 | Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer | terminated | N/A | 9 | Northwestern UniversityOTHER | 1 | May 3, 2019 | clinicaltrials |
| NCT03421327 | Genetic Risk: Whether, When, and How to Tell Adolescents | completed | — | 85 | Johns Hopkins UniversityOTHER | 1 | Feb 7, 2019 | clinicaltrials |
| NCT02557776 | Written Genetic Counseling and Mutation Analysis of BRCA1 and BRCA2 to Patients With Breast Cancer(BRCAsearch) | completed | N/A | 542 | Lund UniversityOTHER | 1 | Feb 6, 2019 | clinicaltrials |
| NCT03319290 | Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies | unknown | — | 2,000 | Data Collection Analysis Business ManagementOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT03067389 | Combined Breast Cancer Risk Study | completed | — | 553 | Myriad Genetic Laboratories, Inc.INDUSTRY | 1 | Jan 15, 2019 | clinicaltrials |
| NCT03495544 | Study Estimating Association Between Germline Mutations and PD-L1 Expression in Breast Cancer | unknown | — | 390 | Tatarstan Cancer CenterOTHER | 1 | Apr 12, 2018 | clinicaltrials |
| NCT00633607 | Hereditary Colorectal and Associated Tumor Registry Study | completed | — | 114 | University of PittsburghOTHER | 1 | Feb 19, 2018 | clinicaltrials |
| NCT01853306 | A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors | completed | Phase 1 | 71 | AbbVieINDUSTRY | 0 | Nov 21, 2017 | clinicaltrials |
| NCT03081455 | Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes | completed | — | 145 | Myriad Genetic Laboratories, Inc.INDUSTRY | 1 | Aug 8, 2017 | clinicaltrials |
| NCT00971620 | Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin | completed | Phase 2 | 18 | National Cancer Institute (NCI)NIH | 1 | Apr 7, 2017 | clinicaltrials |
| NCT01353300 | Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer | completed | — | 31 | Children's Oncology GroupNETWORK | 0 | Jul 11, 2016 | clinicaltrials |
Data updated 22 days agoSource updated Jul 1, 2024source: clinicaltrials